Efficacy of medium molecular weight toxin clearance in manual mixed online hemodiafiltration vs. pre- and post-dilution online hemodiafiltration and conventional hemodialysis: A crossover observational study

Keywords: hemodiafiltration, dilution techniques, beta 2-microglobulin, prolactin, clearance.

Abstract

The effectiveness of various hemodiafiltration (HDF) modes in removing different toxins is not fully understood. The present study aimed to compare the efficacy of manual mixed online HDF with pre-dilution online HDF, post-dilution online HDF, and conventional hemodialysis in clearing medium molecular weight toxins.

Methods. This single-center, crossover observational study included 11 patients (7 males, 4 females) aged 48-85 years (mean age 65.2±11.7) with a dialysis vintage of 24-455 months (mean duration 126±123 months), including 10-29 months (mean duration 19.5±6.4) on HDF. The study focused on the removal of two medium molecular weight molecules: beta 2-microglobulin and the larger prolactin. The effectiveness of various dialysis modes was evaluated in single sessions for each patient, including pre-dilution online HDF (Group A), post-dilution online HDF (Group B), a mixed dilution model with post-dilution during the first half of the session and pre-dilution during the second half (Group C), and conventional hemodialysis (Group D).

Results. A statistically significant difference in the reduction of serum beta 2-microglobulin levels was observed in Group B compared to Group A (70.6±3.1% vs. 64.4±2.7%, p<0.0001) and Group C (70.6±3.1% vs. 65.9±4.9%, p<0.001), with no significant difference between Groups A and C (p=NS). For serum prolactin levels, the greatest reduction was noted in Group B, with significant differences compared to Group A (52.5±8.9% vs. 36.2±9.5%, p<0.001) and Group C (52.5±8.9% vs. 46.9±5.2%, p=0.03). Additionally, Group C showed a significant difference compared to Group A (46.9±5.2% vs. 36.2±9.5%, p<0.005).

Conclusions. Post-dilution HDF is the most effective mode for removing beta 2-microglobulin and prolactin. Mixed dilution HDF also shows significant efficacy, surpassing pre-dilution HDF in toxin clearance. These findings highlight the advantage of post-dilution techniques in managing medium molecular weight toxins. Further research is needed to explore these results in greater detail and to confirm their clinical implications.

Downloads

Download data is not yet available.

References

Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int.2006;69(11):2087-93. doi: 10.1038/sj.ki.5000447.

Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol.2012;23:1087-96. doi: 10.1681/ASN.2011121140.

Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol.2013;24:487-97. doi: 10.1681/ASN.2012080875.

Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant.2013;25:192-202. doi: 10.1093/ndt/gfs407.

Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, et al. Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med.2023;389:700-9. doi: 10.1056/NEJMoa2304820.

Miyata T, Jadoul M, Kurokawa K, Van Ypersele de Strihou C. Beta-2 microglobulin in renal disease. J Am Soc Nephrol. 1998;9:1723-35. doi: 10.1681/ASN.V991723.

Maduell F. Is there an ‘optimal dose’ of hemodiafiltration? Blood Purif. 2015;40(Suppl 1):17-23. doi: 10.1159/000437409.

Masakane I, Kikuchi K, Kawanishi H. Evidence for the clinical advantages of predilution on-line hemodiafiltration. Contrib Nephrol.2017;189:17-23. doi: 10.1159/000450635.

Schiffl H. High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode. Int Urol Nephrol.2020;52:1501-06. doi: 10.1007/s11255-020-02489-9.

Shin S-K, Jo Y-Il. Why should we focus on high-volume hemodiafiltration? Kidney Res Clin Pract.2022;41(6):670-81. doi: 10.23876/j.krcp.21.268.

Penne EL, van der Weerd NC, Bots ML, van den Dorpel MA, Grooteman MP, Lévesque R, et al. Patient- and treatment-related determinants of convective volume in post-dilution haemodiafiltration in clinical practice. Nephrol Dial Transplant. 2009;24:3493-9. doi: 10.1093/ndt/gfp265.

Davenport A, Peters SAE, Bots ML, Canaud B, Grooteman MP, Asci G, et al. HDF Pooling Project Investigators. Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: The effect of adjustment for body size. Kidney Int. 2016;89:193-9. doi: 10.1038/ki.2015.264.

Canaud B, Barbieri C, Marcelli D, Bellocchio F, Bowry S, Mari F, et al. Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int. 2015;88:1108-16. doi: 10.1038/ki.2015.139.

Tattersall JE, Ward RA. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013;28(3):542-50. doi: 10.1093/ndt/gfs530.

Kikuchi K, Hamano T, Wada A, Nakai S, Masakane I. Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis. Kidney Int. 2019;95:929-38. doi: 10.1016/j.kint.2018.10.036.

Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33(1):27-39. doi: 10.1093/ajcn/33.1.27.

Pedrini LA, De Cristofaro V, Pagliari B, Samà F. Mixed predilution and postdilution online hemodiafiltration compared with traditional infusion modes. Kidney Int. 2000;58:2155-65. doi: 10.1111/j.1523-1755.2000.00389.x.

Pedrini LA, Zawada AM, Winter AC, Pham J, Klein G, Wolf M, et al. Effects of high-volume online mixed-haemodiafiltration on anemia management in dialysis patients. PLoS ONE 2019;14(2):e0212795. doi: 10.1371/journal.pone.0212795.

Park KS, Kang EW, Chang TI, Jo W, Park JT, Yoo T-H, et al. Mixed-versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial. Kidney Res Clin Pract. 2021;40(3):445-56. doi: 10.23876/j.krcp.21.044.

Nube MJ, Peters SAE, Blankestijn PJ, Canaud B, Davenport A, Grooteman MPC, et al. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis. Nephrol Dial Transplant. 2017;32(3):548-55. doi: 10.1093/ndt/gfw381.

Leypoldt JK, Cheung AK, Deeter RB. Rebound kinetics of b2-microglobulin after hemodialysis. Kidney Int. 1999;56:1571-7. doi: 10.1046/j.1523-1755.1999.00669.x.

Blankestijn PJ, Fischer KI, Barth C, Cromm K, Canaud B, Davenport A, et al. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. BMJ Open. 2020;10(2):e033228. doi: 10.1136/bmjopen-2019-033228.

de Sequera P, Albalate M, Pérez-García R, Corchete E, Puerta M, Ortega-Díaz M, et al. A comparison of the effectiveness of two online haemodiafiltration modalities: mixed versus post-dilution. Nefrologia.2013;33(6):779-87. doi: 10.3265/Nefrologia.pre2013.Sep.12223.

Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol. (Oxf).1992;37:365-72. doi: 10.1111/j.1365-2265.1992.tb02340.x.

Friedrich JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, et al. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol.2012;7(2):207-15. doi: 10.2215/CJN.06840711.

Chan MJ, Hutchison CA. Large uremic toxins: an unsolved problem in end-stage kidney disease. Nephrol Dial Transplant.2018;33(Suppl_3):iii6-iii11. doi: 10.1093/ndt/gfy179.

Santos A, Macías N, Cruzado L, Vega A. The removal capacity of asymmetric cellulose triacetate during post-dilution online hemodiafiltration. Kidney Res Clin Pract.2021;40(2):325-7. doi: 10.23876/j.krcp.20.243.

Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int. 2003;64:305-13. doi: 10.1046/j.1523-1755.2003.00043.x.

Maduell F, Rodas L, Broseta JJ, Gómez M, Font MX, Molina A, et al. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration. Artificial Organs.2019;43(10):1014-21. doi: 10.1111/aor.13480.


Abstract views: 472
PDF Downloads: 331
Published
2024-08-18
How to Cite
Mavromatidis, K., Kalogiannidou, I., Passadakis, P., & Katzel Axmet, G. (2024). Efficacy of medium molecular weight toxin clearance in manual mixed online hemodiafiltration vs. pre- and post-dilution online hemodiafiltration and conventional hemodialysis: A crossover observational study. Ukrainian Journal of Nephrology and Dialysis, (3(83), 14-24. https://doi.org/10.31450/ukrjnd.3(83).2024.03